Fucoidan reduces inflammatory response in a rat model of hepatic ischemia–reperfusion injury

Canadian Journal of Physiology and Pharmacology - Tập 93 Số 11 - Trang 999-1005 - 2015
Xiaojing Li1, Qifa Ye1
1Transplant Medical Engineering Research Center, Third Xiangya Hospital, Central South University, Hunan, China.

Tóm tắt

Ischemia–reperfusion (I/R) injury after a liver transplant is a major cause of severe complications that lead to graft dysfunction. Fucoidan, a complex of sulfated polysaccharides derived from marine brown algae, demonstrated antiapoptotic as well as potential anti-inflammatory properties in previous studies. Fucoidan has also shown protective effects on I/R-injured kidney and heart. However, whether fucoidan can attenuate hepatic I/R injury has not been examined. To clarify the role of fucoidan in hepatic I/R injury, Sprague–Dawley rats were subjected to sham operation or ischemia followed by reperfusion with treatment of saline or fucoidan (50, 100, or 200 mg·(kg body mass)−1·d−1). The fucoidan-treated group showed decreased levels of alanine aminotransferase and aspartate aminotransferase compared with the control group. Myeloperoxidase and malondialdehyde activities and mRNA levels of CD11b in the fucoidan-treated group were significantly decreased. Hepatocellular swelling/necrosis, sinusoidal/vascular congestion, and inflammatory cell infiltration were also attenuated in the fucoidan group. The expression of TNF-α, IL-6, IL-1β, CXCL-10, VCAM-1, and ICAM-1 were markedly decreased in the samples from the fucoidan-treated group. Fucoidan largely prevented activation of the inflammatory signaling pathway, compared with the control group. In summary, fucoidan can protect the liver from I/R injury through suppressing activation of the inflammatory signaling pathway, as well as the expression of inflammatory mediators, and inflammatory cell infiltration.

Từ khóa


Tài liệu tham khảo

10.1111/j.1600-6143.2006.01595.x

10.1017/S0007114508137886

10.1016/S0008-6215(02)00053-8

10.1371/journal.pone.0056224

10.1016/S0008-6215(99)00148-2

10.1093/glycob/cwm014

10.1016/S0014-4800(03)00008-X

10.1152/ajpgi.00568.2005

10.1172/JCI12568

10.1097/FJC.0b013e3182308c64

10.1097/00005344-199712000-00003

10.1189/jlb.0307180

10.1089/ars.2013.5486

10.1160/TH05-08-0546

10.1016/S0002-9610(00)00573-0

Su J.F., 2003, Biomed. Environ. Sci., 16, 1

Suzuki S., 1993, Transplantation, 55, 1265, 10.1097/00007890-199306000-00011

10.3748/wjg.v17.i33.3785

Tarantino G., 2011, J. Biol. Regul. Homeost. Agents, 25, 47

10.3748/wjg.v17.i48.5280

10.1002/jcp.20860

10.4049/jimmunol.175.11.7661

Walsh K.B., 2009, Exp. Clin. Transplant., 7, 78

10.1111/j.1478-3231.2007.01564.x

10.1055/s-2003-40634

Thông tin
Thông tin xuất bản

Canadian Journal of Physiology and Pharmacology

Tập 93 Số 11

999-1005

Thông tin tác giả